Susilo Wagino MulyoThe landscape of managing obstructive sleep apnea (OSA) is undergoing a significant transformation, driven in part by the increasing use of Glucagon-like peptide-1 receptor agonists (GLP-1s). These medications, initially developed…
Susilo Wagino MulyoThe emergence of Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Ozempic and the recently FDA-approved Zepbound, has opened new avenues in the treatment of obstructive sleep apnea (OSA), particularly for…
Pranda MichaelaThis month, after more than a decade of persistent advocacy and the invaluable input of over 14,000 patients and health professionals, polycystic ovary syndrome (PCOS) has officially been renamed. The…
Susilo Wagino MulyoThe treatment paradigm for obstructive sleep apnea (OSA) is undergoing a significant transformation, propelled by the emergence of Glucagon-like peptide-1 receptor agonists (GLP-1s). While popular GLP-1s like Ozempic have garnered…
Susilo Wagino MulyoThe landscape of sleep apnea treatment is undergoing a significant transformation with the emergence of Glucagon-like Peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for type 2 diabetes.…
Susilo Wagino MulyoGlucagon-like peptide-1 receptor agonists (GLP-1s), a class of medications originally developed for type 2 diabetes, have gained significant attention for their efficacy in weight management, which in turn holds promise…
Hanik KholidahIn a landmark decision that marks one of the most significant shifts in women’s healthcare in decades, the medical community has officially moved to rename Polycystic Ovary Syndrome (PCOS) to…
Susilo Wagino MulyoThe landscape of treating obstructive sleep apnea (OSA), a pervasive condition affecting millions, is undergoing a significant transformation with the advent and increasing adoption of glucagon-like peptide-1 receptor agonists (GLP-1s).…
Hanik KholidahThe transition from active cancer treatment to the status of "cancer-free" is frequently characterized in public discourse as a definitive finish line, yet for actress Miranda McKeon, the reality of…
Susilo Wagino MulyoThe landscape of sleep apnea treatment is undergoing a significant transformation with the emergence of Glucagon-like peptide-1 receptor agonists (GLP-1s), a class of medications initially developed for type 2 diabetes…
